Literature DB >> 6787458

Type 2 GM1 gangliosidosis with long survival and neuronal ceroid lipofuscinosis.

J A Lowden, J W Callahan, R A Gravel, M A Skomorowski, L Becker, J Groves.   

Abstract

Neurologic deterioration began in a girl before age 2 years. By 4 she was spastic and decerebrate. GM1 gangliosidosis was diagnosed by absence of beta-galactosidase activity in leukocytes and fibroblasts. She died at 17 years. Her small brain contained only 2.61 mumole glycolipid N-acetylneuraminic acid per gram, and was filled with autofluorescent material. GM1 gangliosidosis was confirmed by the presence of membranous cytoplasmic bodies, by the absence of beta-galactosidase, and by failure of complementation when the patient's fibroblasts were fused with cells from other forms of GM1 gangliosidosis. The autofluorescent material probably accumulated because of the long survival rather than the primary enzyme defect.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6787458     DOI: 10.1212/wnl.31.6.719

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  A case of adult neuronal ceroid-lipofuscinosis with the appearance of membranous cytoplasmic bodies localized in the spinal anterior horn.

Authors:  E Iseki; N Amano; S Yokoi; Y Yamada; K Suzuki; M Yazaki
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

2.  Increased globotriaosylceramide in familial dysautonomia.

Authors:  P Strasberg; H Yeger; I Warren
Journal:  Lipids       Date:  1992-12       Impact factor: 1.880

3.  Autofluorescence emission spectra of neuronal lipopigment in a case of adult-onset ceroidosis (Kufs' disease).

Authors:  J H Dowson
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

4.  Anderson-Fabry's disease: neuropathological and neurochemical investigation.

Authors:  F Tagliavini; V Pietrini; F Gemignani; A Lechi; R Pallini; A Federico
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

5.  GM2 Gangliosidosis in Shiba Inu Dogs with an In-Frame Deletion in HEXB.

Authors:  A Kolicheski; G S Johnson; N A Villani; D P O'Brien; T Mhlanga-Mutangadura; D A Wenger; K Mikoloski; J S Eagleson; J F Taylor; R D Schnabel; M L Katz
Journal:  J Vet Intern Med       Date:  2017-08-20       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.